Hi Ezq
”….PromarkerD test in predicting diabetic kidney disease was “published”today in journal PLOS ONE…”
I don’t recall being previously advised that it was actually published in PLOS ONE a highly regarded peer-reviewed open access journal.
This exposure is phenomenal.
The publication is quite an in-depth look at PromarkerD & available for all to read.
Ann: Clinical Utility Study demonstrates PromarkerD test benefits, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.005(1.27%) |
Mkt cap ! $63.83M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 39.5¢ | 37.5¢ | $70.18K | 183.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 76292 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 24754 | 2 |
View Market Depth
| Last trade - 16.10pm 28/07/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |